The causal relation between human papillomavirus and cervical cancer

F. X. Bosch, A. Lorincz, N. Muñoz, C. J L M Meijer, K. V. Shah

Research output: Contribution to journalArticle

Abstract

During the 1990s, epidemiological studies, supported by molecular technology, provided evidence on the causal role of some human papillomavirus (HPV) infections in the development of cervical cancer. This association has been evaluated under all proposed sets of causality criteria and endorsed by the scientific community and major review institutes. The finding is universally consistent, and to date there are no documented alternative hypotheses for the aetiology of cervical cancer. HPV has been proposed as the first ever identified, "necessary cause" of a human cancer. In practical terms, the concept of a necessary cause implies that cervical cancer does not and will not develop in the absence of the persistent presence of HPV DNA. Cervical cancer is still the second most common cancer in women worldwide, although it is a theoretically preventable disease. In developed parts of the world, and in populations where cytology based programmes are established, it would be beneficial to add HPV testing to the screening protocol. HPV testing was shown by several studies, including one randomised trial, to be of help in solving the ambiguous cases generated by cytology reading. In populations where cytology programmes are either not in place or are not efficient, HPV testing should now be considered and evaluated as an alternative test for primary screening. Prevention of exposure to high risk HPV types by vaccination may prove to be the most efficient and logistically feasible preventive intervention for cervical cancer. At this stage of development, regulatory agencies are requested to evaluate the scientific evidence and weigh its implications in relation to costs, public health investments, and policy. This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings.

Original languageEnglish (US)
Pages (from-to)244-265
Number of pages22
JournalJournal of Clinical Pathology
Volume55
Issue number4
StatePublished - 2002

Fingerprint

Uterine Cervical Neoplasms
Cell Biology
Papillomavirus Infections
Population Control
Public Policy
Health Policy
Causality
Reading
Epidemiologic Studies
Neoplasms
Vaccination
Public Health
Technology
Costs and Cost Analysis
DNA
Population

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Bosch, F. X., Lorincz, A., Muñoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55(4), 244-265.

The causal relation between human papillomavirus and cervical cancer. / Bosch, F. X.; Lorincz, A.; Muñoz, N.; Meijer, C. J L M; Shah, K. V.

In: Journal of Clinical Pathology, Vol. 55, No. 4, 2002, p. 244-265.

Research output: Contribution to journalArticle

Bosch, FX, Lorincz, A, Muñoz, N, Meijer, CJLM & Shah, KV 2002, 'The causal relation between human papillomavirus and cervical cancer', Journal of Clinical Pathology, vol. 55, no. 4, pp. 244-265.
Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology. 2002;55(4):244-265.
Bosch, F. X. ; Lorincz, A. ; Muñoz, N. ; Meijer, C. J L M ; Shah, K. V. / The causal relation between human papillomavirus and cervical cancer. In: Journal of Clinical Pathology. 2002 ; Vol. 55, No. 4. pp. 244-265.
@article{b89eeca0e9a94e62be4c8ffeaa9d1c13,
title = "The causal relation between human papillomavirus and cervical cancer",
abstract = "During the 1990s, epidemiological studies, supported by molecular technology, provided evidence on the causal role of some human papillomavirus (HPV) infections in the development of cervical cancer. This association has been evaluated under all proposed sets of causality criteria and endorsed by the scientific community and major review institutes. The finding is universally consistent, and to date there are no documented alternative hypotheses for the aetiology of cervical cancer. HPV has been proposed as the first ever identified, {"}necessary cause{"} of a human cancer. In practical terms, the concept of a necessary cause implies that cervical cancer does not and will not develop in the absence of the persistent presence of HPV DNA. Cervical cancer is still the second most common cancer in women worldwide, although it is a theoretically preventable disease. In developed parts of the world, and in populations where cytology based programmes are established, it would be beneficial to add HPV testing to the screening protocol. HPV testing was shown by several studies, including one randomised trial, to be of help in solving the ambiguous cases generated by cytology reading. In populations where cytology programmes are either not in place or are not efficient, HPV testing should now be considered and evaluated as an alternative test for primary screening. Prevention of exposure to high risk HPV types by vaccination may prove to be the most efficient and logistically feasible preventive intervention for cervical cancer. At this stage of development, regulatory agencies are requested to evaluate the scientific evidence and weigh its implications in relation to costs, public health investments, and policy. This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings.",
author = "Bosch, {F. X.} and A. Lorincz and N. Mu{\~n}oz and Meijer, {C. J L M} and Shah, {K. V.}",
year = "2002",
language = "English (US)",
volume = "55",
pages = "244--265",
journal = "Journal of Clinical Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - The causal relation between human papillomavirus and cervical cancer

AU - Bosch, F. X.

AU - Lorincz, A.

AU - Muñoz, N.

AU - Meijer, C. J L M

AU - Shah, K. V.

PY - 2002

Y1 - 2002

N2 - During the 1990s, epidemiological studies, supported by molecular technology, provided evidence on the causal role of some human papillomavirus (HPV) infections in the development of cervical cancer. This association has been evaluated under all proposed sets of causality criteria and endorsed by the scientific community and major review institutes. The finding is universally consistent, and to date there are no documented alternative hypotheses for the aetiology of cervical cancer. HPV has been proposed as the first ever identified, "necessary cause" of a human cancer. In practical terms, the concept of a necessary cause implies that cervical cancer does not and will not develop in the absence of the persistent presence of HPV DNA. Cervical cancer is still the second most common cancer in women worldwide, although it is a theoretically preventable disease. In developed parts of the world, and in populations where cytology based programmes are established, it would be beneficial to add HPV testing to the screening protocol. HPV testing was shown by several studies, including one randomised trial, to be of help in solving the ambiguous cases generated by cytology reading. In populations where cytology programmes are either not in place or are not efficient, HPV testing should now be considered and evaluated as an alternative test for primary screening. Prevention of exposure to high risk HPV types by vaccination may prove to be the most efficient and logistically feasible preventive intervention for cervical cancer. At this stage of development, regulatory agencies are requested to evaluate the scientific evidence and weigh its implications in relation to costs, public health investments, and policy. This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings.

AB - During the 1990s, epidemiological studies, supported by molecular technology, provided evidence on the causal role of some human papillomavirus (HPV) infections in the development of cervical cancer. This association has been evaluated under all proposed sets of causality criteria and endorsed by the scientific community and major review institutes. The finding is universally consistent, and to date there are no documented alternative hypotheses for the aetiology of cervical cancer. HPV has been proposed as the first ever identified, "necessary cause" of a human cancer. In practical terms, the concept of a necessary cause implies that cervical cancer does not and will not develop in the absence of the persistent presence of HPV DNA. Cervical cancer is still the second most common cancer in women worldwide, although it is a theoretically preventable disease. In developed parts of the world, and in populations where cytology based programmes are established, it would be beneficial to add HPV testing to the screening protocol. HPV testing was shown by several studies, including one randomised trial, to be of help in solving the ambiguous cases generated by cytology reading. In populations where cytology programmes are either not in place or are not efficient, HPV testing should now be considered and evaluated as an alternative test for primary screening. Prevention of exposure to high risk HPV types by vaccination may prove to be the most efficient and logistically feasible preventive intervention for cervical cancer. At this stage of development, regulatory agencies are requested to evaluate the scientific evidence and weigh its implications in relation to costs, public health investments, and policy. This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings.

UR - http://www.scopus.com/inward/record.url?scp=0036221471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036221471&partnerID=8YFLogxK

M3 - Article

C2 - 11919208

AN - SCOPUS:0036221471

VL - 55

SP - 244

EP - 265

JO - Journal of Clinical Pathology

JF - Journal of Clinical Pathology

SN - 0021-9746

IS - 4

ER -